TY - JOUR
T1 - Yttrium-90 radioembolization for hepatocellular carcinoma
AU - Hickey, Ryan M.
AU - Lewandowski, Robert J.
AU - Salem, Riad
N1 - Publisher Copyright:
© 2016 Published by Elsevier Inc.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - 90Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of primary and metastatic hepatic malignancies. In the treatment of intermediate- and advanced-stage hepatocellular carcinoma, 90Y radioembolization provides favorable outcomes with minimal side effects, offering an alternative treatment option to other transarterial therapies, such as bland embolization and chemoembolization. This review provides an overview of the use of 90Y radioembolization in the treatment of hepatocellular carcinoma, including patient selection criteria, dosimetry, and clinical outcomes.
AB - 90Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of primary and metastatic hepatic malignancies. In the treatment of intermediate- and advanced-stage hepatocellular carcinoma, 90Y radioembolization provides favorable outcomes with minimal side effects, offering an alternative treatment option to other transarterial therapies, such as bland embolization and chemoembolization. This review provides an overview of the use of 90Y radioembolization in the treatment of hepatocellular carcinoma, including patient selection criteria, dosimetry, and clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84958779419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958779419&partnerID=8YFLogxK
U2 - 10.1053/j.semnuclmed.2015.10.011
DO - 10.1053/j.semnuclmed.2015.10.011
M3 - Review article
C2 - 26897714
AN - SCOPUS:84958779419
SN - 0001-2998
VL - 46
SP - 105
EP - 108
JO - Seminars in Nuclear Medicine
JF - Seminars in Nuclear Medicine
IS - 2
ER -